{
    "2019-02-01": [
        [
            {
                "time": "2019-02-01",
                "original_text": "Health Care Sector Update for 02/01/2019: TTNP, CTIC, OPK, JNJ, PFE, MRK, ABT, AMGN",
                "features": {
                    "keywords": [
                        "Health Care",
                        "Sector Update",
                        "PFE",
                        "MRK",
                        "ABT",
                        "AMGN"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-01",
                "original_text": "Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Q4 Earnings",
                        "Pipeline Updates",
                        "PFE"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-01",
                "original_text": "Pfizer Receives Positive CHMP Opinion for Vizimpro® (dacomitinib) for the First-line Treatment of Adult Patients with Locally Advanced Or Metastatic Non-Small Cell Lung Cancer with EGFR-Activating Mutations",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Positive CHMP Opinion",
                        "Vizimpro",
                        "Non-Small Cell Lung Cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-01",
                "original_text": "Dow 30 Stock Roundup: MCD, BA, 3M, MSFT, PFE, V Earnings Impress",
                "features": {
                    "keywords": [
                        "Dow 30",
                        "Stock Roundup",
                        "Earnings Impress",
                        "PFE"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "diversified"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-01",
                "original_text": "Xeljanz: Pfizer’s Key Immunology Asset in Fiscal 2019",
                "features": {
                    "keywords": [
                        "Xeljanz",
                        "Pfizer",
                        "Immunology Asset",
                        "Fiscal 2019"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-01",
                "original_text": "Pfizer Gets Positive CHMP Opinion For Vizimpro 45 Mg",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Positive CHMP Opinion",
                        "Vizimpro",
                        "45 Mg"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-01",
                "original_text": "Watch These Healthcare Stocks in First Week of February",
                "features": {
                    "keywords": [
                        "Healthcare Stocks",
                        "First Week",
                        "February"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-02-01",
                "original_text": "Pharma Catches Another Case Of M&A Fever",
                "features": {
                    "keywords": [
                        "Pharma",
                        "M&A Fever"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-01",
                "original_text": "Top Analyst Reports for Boeing, Thermo Fisher & Anthem",
                "features": {
                    "keywords": [
                        "Analyst Reports",
                        "Boeing",
                        "Thermo Fisher",
                        "Anthem"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "diversified"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}